PortfoliosLab logoPortfoliosLab logo
EQRR vs. GERM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

EQRR vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Equities for Rising Rates ETF (EQRR) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


EQRR

1D
-0.58%
1M
8.10%
YTD
27.33%
6M
27.15%
1Y
41.70%
3Y*
22.28%
5Y*
12.33%
10Y*

GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

EQRR vs. GERM - Yearly Performance Comparison


2026 (YTD)20252024
EQRR
ProShares Equities for Rising Rates ETF
27.33%15.49%1.72%
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%

EQRR vs. GERM - Sectors Allocation Comparison


Sectors
EQRR
GERM

Technology

32.1%

-

Energy

26.8%

-

Financial Services

20.5%
0.4%

Communication Services

11.7%

-

Consumer Cyclical

4.8%

-

Industrials

4.2%

-

Basic Materials

-

-

Consumer Defensive

-

-

Healthcare

-

99.3%

Real Estate

-

-

Utilities

-

-

Technology

EQRR
32.1%
GERM

-

Energy

EQRR
26.8%
GERM

-

Financial Services

EQRR
20.5%
GERM
0.4%

Communication Services

EQRR
11.7%
GERM

-

Consumer Cyclical

EQRR
4.8%
GERM

-

Industrials

EQRR
4.2%
GERM

-

Basic Materials

EQRR

-

GERM

-

Consumer Defensive

EQRR

-

GERM

-

Healthcare

EQRR

-

GERM
99.3%

Real Estate

EQRR

-

GERM

-

Utilities

EQRR

-

GERM

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EQRR vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EQRR
EQRR Risk / Return Rank: 9191
Overall Rank
EQRR Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
EQRR Sortino Ratio Rank: 8989
Sortino Ratio Rank
EQRR Omega Ratio Rank: 8888
Omega Ratio Rank
EQRR Calmar Ratio Rank: 9595
Calmar Ratio Rank
EQRR Martin Ratio Rank: 9595
Martin Ratio Rank

GERM
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EQRR vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Equities for Rising Rates ETF (EQRR) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


EQRRGERMDifference

Sharpe ratio

Return per unit of total volatility

3.11

Sortino ratio

Return per unit of downside risk

4.10

Omega ratio

Gain probability vs. loss probability

1.56

Calmar ratio

Return relative to maximum drawdown

8.47

Martin ratio

Return relative to average drawdown

31.54

EQRR vs. GERM - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


EQRRGERMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.11

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.58

Sharpe Ratio (All Time)

Calculated using the full available price history

0.43

Drawdowns

EQRR vs. GERM - Drawdown Comparison

The maximum EQRR drawdown since its inception was -57.93%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for EQRR and GERM.


Loading charts...

Drawdown Indicators


EQRRGERMDifference

Max Drawdown

Largest peak-to-trough decline

-57.93%

0.00%

-57.93%

Max Drawdown (1Y)

Largest decline over 1 year

-4.95%

0.00%

-4.95%

Max Drawdown (3Y)

Largest decline over 3 years

-17.75%

Max Drawdown (5Y)

Largest decline over 5 years

-21.75%

Current Drawdown

Current decline from peak

-0.58%

0.00%

-0.58%

Average Drawdown

Average peak-to-trough decline

-10.08%

0.00%

-10.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.33%

0.00%

+1.33%

Volatility

EQRR vs. GERM - Volatility Comparison

ProShares Equities for Rising Rates ETF (EQRR) has a higher volatility of 4.72% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that EQRR's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EQRRGERMDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.72%

0.00%

+4.72%

Volatility (6M)

Calculated over the trailing 6-month period

10.35%

0.00%

+10.35%

Volatility (1Y)

Calculated over the trailing 1-year period

13.50%

0.00%

+13.50%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.39%

0.00%

+21.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.87%

0.00%

+24.87%

EQRR vs. GERM - Expense Ratio Comparison

EQRR has a 0.35% expense ratio, which is lower than GERM's 0.68% expense ratio.


Dividends

EQRR vs. GERM - Dividend Comparison

EQRR's dividend yield for the trailing twelve months is around 1.20%, while GERM has not paid dividends to shareholders.


PositionTTM202520242023202220212020201920182017
EQRR
ProShares Equities for Rising Rates ETF
1.20%1.70%2.17%2.77%2.34%1.71%2.17%2.05%2.47%0.69%
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


EQRR has higher volatility (4.72%) compared to GERM (0.00%). In terms of maximum drawdown, EQRR dropped -57.93% vs GERM's 0.00%.

On 1-year performance, EQRR leads with 41.70% vs 0.00% for GERM. On fees, EQRR is cheaper at 0.35% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, EQRR has performed better with a 41.70% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

EQRR is cheaper with a 0.35% expense ratio, compared with 0.68% for GERM.

EQRR has the higher dividend yield at 1.20%, compared with 0.00% for GERM.

EQRR is categorized as Mid Cap Value Equities, while GERM is Health & Biotech Equities. EQRR tracks Nasdaq US Large Cap Equity Rising Rates Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: ProShares and Amplify. Their fees differ too: 0.35% for EQRR and 0.68% for GERM.

Portfolio Optimizer

Find the right allocation for EQRR and GERM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer